FDA.reportPublic FDA data

FOUNDAYO

Product NDC
0002-4503
11-digit product format
000024503
Labeler code
0002
Product ID
0002-4503_eac65e03-3444-4d6b-acb8-ea4f7a276f03
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
orforglipron
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Eli Lilly and Company
Application
NDA220934
Marketing category
NDA
Marketing start
2026-04-01
Substance
ORFORGLIPRON CALCIUM
Active strength
2.5 mg/1
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
FOUNDAYO
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ORFORGLIPRON CALCIUM2.5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiVI5M9OZV2X
Rxcui2739844, 2739850, 2739852, 2739854, 2739856, 2739858, 2739860, 2739862, 2739864, 2739866, 2739868, 2739870

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0002-4503-01FOUNDAYO30 in 1 BOTTLETABLET, FILM COATED305
0002-4503-31FOUNDAYO1 in 1 CARTONTABLET, FILM COATED15

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0002-4503-01EA - Each0002-4503a4d88124-2011-4909-bfe2-24228205678212026-05-22
0002-4503-31EA - Each0002-4503b2f996cc-ee44-484a-92d0-25a5fdad7b2312026-04-20

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
2739850Foundayo 0.8 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739866Foundayo 14.5 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739870Foundayo 17.2 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739854Foundayo 2.5 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739858Foundayo 5.5 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739862Foundayo 9 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739844orforglipron 0.8 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739864orforglipron 14.5 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739868orforglipron 17.2 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739852orforglipron 2.5 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739856orforglipron 5.5 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739860orforglipron 9 MG Oral TabletPSN8ac446c5-feba-474f-a103-23facb9b5c625
2739850orforglipron 0.8 MG Oral Tablet [Foundayo]SBD8ac446c5-feba-474f-a103-23facb9b5c625
2739866orforglipron 14.5 MG Oral Tablet [Foundayo]SBD8ac446c5-feba-474f-a103-23facb9b5c625
2739870orforglipron 17.2 MG Oral Tablet [Foundayo]SBD8ac446c5-feba-474f-a103-23facb9b5c625
2739854orforglipron 2.5 MG Oral Tablet [Foundayo]SBD8ac446c5-feba-474f-a103-23facb9b5c625
2739858orforglipron 5.5 MG Oral Tablet [Foundayo]SBD8ac446c5-feba-474f-a103-23facb9b5c625
2739862orforglipron 9 MG Oral Tablet [Foundayo]SBD8ac446c5-feba-474f-a103-23facb9b5c625
2739844orforglipron 0.8 MG Oral TabletSCD8ac446c5-feba-474f-a103-23facb9b5c625
2739864orforglipron 14.5 MG Oral TabletSCD8ac446c5-feba-474f-a103-23facb9b5c625
2739868orforglipron 17.2 MG Oral TabletSCD8ac446c5-feba-474f-a103-23facb9b5c625
2739852orforglipron 2.5 MG Oral TabletSCD8ac446c5-feba-474f-a103-23facb9b5c625
2739856orforglipron 5.5 MG Oral TabletSCD8ac446c5-feba-474f-a103-23facb9b5c625
2739860orforglipron 9 MG Oral TabletSCD8ac446c5-feba-474f-a103-23facb9b5c625
2739850Foundayo 0.8 MG (equivalent to orforglipron calcium 0.817 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739866Foundayo 14.5 MG (equivalent to orforglipron calcium 14.81 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739870Foundayo 17.2 MG (equivalent to orforglipron calcium 17.57 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739854Foundayo 2.5 MG (equivalent to orforglipron calcium 2.554 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739858Foundayo 5.5 MG (equivalent to orforglipron calcium 5.619 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739862Foundayo 9 MG (equivalent to orforglipron calcium 9.194 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739844orforglipron 0.8 MG (equivalent to orforglipron calcium 0.817 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739864orforglipron 14.5 MG (equivalent to orforglipron calcium 14.81 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739868orforglipron 17.2 MG (equivalent to orforglipron calcium 17.57 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739852orforglipron 2.5 MG (equivalent to orforglipron calcium 2.554 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739856orforglipron 5.5 MG (equivalent to orforglipron calcium 5.619 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625
2739860orforglipron 9 MG (equivalent to orforglipron calcium 9.194 MG) Oral TabletSY8ac446c5-feba-474f-a103-23facb9b5c625

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
0002-4503-010000245030130 in 1 BOTTLEHistorical
0002-4503-31000024503311 BOTTLE in 1 CARTON (0002-4503-31) / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4503-01) 1 bottle2026-04-01NoNoHistorical